Medicine and Dentistry
Ganglioneuroblastoma
82%
Neoplasm
48%
Pediatrics
32%
Organoid
25%
Pediatric Cancer
21%
Childhood Cancer
17%
Neuroblastoma Cell
16%
Malignant Neoplasm
15%
T Cell
14%
Solid Malignant Neoplasm
13%
Cancer
12%
Immunotherapy
12%
Neuroblastoma Cell Line
11%
RNA Sequence
10%
Disease
8%
Targeted Therapy
8%
In Vitro
8%
Oncology
7%
Personalized Medicine
7%
Programmed Cell Death
6%
Drug Sensitivity
6%
Messenger RNA
6%
Experimental Therapy
6%
Tumor
6%
High Throughput Screening
5%
Protein P53
5%
Tumor Cell
5%
Drug Screening
5%
Cell Line
5%
Xenograft
5%
Adolescence
5%
Biological Marker
5%
Whole Genome Sequencing
5%
Transcriptomics
5%
Keyphrases
Neuroblastoma
100%
Tumor
31%
Pediatric
19%
Neuroblastoma Cells
18%
Pediatric Tumors
15%
Pediatric Cancer
12%
Neuroblastoma Cell Line
11%
Neuroblastoma Tumor
11%
Organoids
11%
Precision Oncology
10%
Tumor Organoids
9%
Children with Cancer
9%
Therapeutic Target
8%
High-risk Neuroblastoma
8%
Pediatric Malignancy
8%
Pediatric Oncology
8%
Childhood Cancer
7%
T Cells
7%
MYCN Amplification
7%
Whole Genome Sequencing
6%
Tumor Cells
6%
Innovative Therapies
6%
Poor Prognosis
6%
RNA Sequencing (RNA-seq)
6%
Targeted Treatment
6%
Chromothripsis
6%
Targeted Drugs
5%
Apoptosis
5%
Cyclin D1 (CCND1)
5%
Aberrations
5%
Relapsed or Refractory
5%
Patient-derived Organoids
5%
Drug Development
5%
Cyclin-dependent Kinase 4 (CDK4)
5%
Single-cell RNA Sequencing (scRNA-seq)
5%
Patient-specific
5%
High-throughput Screening
5%
Adoptive Cell Therapy
5%
Genetic Modification
5%
RAS-MAPK Pathway
5%
Clinical Trials
5%
